Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report

As CureVac strives to convince the world that it won’t let its disappointing first-generation mRNA Covid-19 vaccine hold it down, Bayer reportedly won’t be sticking around to help manufacture the new candidates.